Since we observed a consistent change in p38 phosphorylation status in all the oral cancer cells, we next thought of using a p38 inhibitor, SB203580, to further evaluate the mechanistic details of luteolin-7-O-glucoside action. The gene discussed is MAPK14; the disease is lip and oral cavity carcinoma.